Suven Pharmaceuticals Limited (NSE: SUVENPHAR)
India flag India · Delayed Price · Currency is INR
1,200.15
+49.05 (4.26%)
Sep 6, 2024, 3:30 PM IST

Suven Pharmaceuticals Company Description

Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally.

It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies.

The company was founded in 1989 and is based in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Berhyanda Limited.

Suven Pharmaceuticals Limited
Country India
Founded 1989
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,193
CEO Sudhir Singh

Contact Details

Address:
Galaxy Towers
Hyderabad, 500081
India
Phone 91 40 2354 9414
Website suvenpharm.com

Stock Details

Ticker Symbol SUVENPHAR
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE03QK01018
SIC Code 2834

Key Executives

Name Position
Dr. Sudhir Kumar Singh Ph.D. Chief Executive Officer
Vaidheesh Annaswamy Executive Chairman
Himanshu Agarwal Chief Financial Officer
Cyndrella Carvalho Head of Investor Relations
Gaurav Narain Bahadur Chief Human Resources Officer
Dr. Vetukuri Venkata Naga Kali Vara Prasada Raju MD and Director
Subba Raju Komaravolu Chief Strategy Officer
Brian Shaughnessy Chief Commercial Officer
Sunder Venkatraman Vice President of Corporate Affairs